Literature DB >> 28414148

A close collaboration of chitosan with lipid colloidal carriers for drug delivery applications.

Loïc Bugnicourt1, Catherine Ladavière2.   

Abstract

Chitosan and lipid colloids have separately shown a growing interest in the field of drug delivery applications. Their success is mainly due to their interesting physicochemical behaviors, as well as their biological properties such as bioactivity and biocompatibility. While chitosan is a well-known cationic polysaccharide with the ability to strongly interact with drugs and biological matrices through mainly electrostatic interactions, lipid colloids are carriers particularly recognized for the drug vectorization. In recent years, the combination of both entities has been considered because it offers new systems which gather the advantages of each of them to efficiently deliver various types of bioactive species. The purpose of this review is to describe these associations between chemically-unmodified chitosan chains (solubilized or dispersed) and lipid colloids (as nanoparticles or organized in lipid layers), as well as their potential in the drug delivery area so far. Three assemblies have mainly been reported in the literature: i) lipid nanoparticles (solid lipid nanoparticles or nanostructured lipid carriers) coated with chitosan chains, ii) lipid vesicles covered with chitosan chains, and iii) chitosan chains structured in nanoparticles with a lipid coating. Their elaboration processes, their physicochemical characterization, and their biological studies are detailed and discussed herein. The different bioactive species (drugs and bio(macro)molecules) incorporated in these assemblies, their maximal incorporation efficiency, and their loading capacity are also presented. This review reveals the versatility of these assemblies. Depending on the organization of lipids (i.e., nanoparticles or vesicles) and the state of polymer chains (i.e., solubilized or dispersed under the form of nanoparticles), a large variety of drugs can be successfully incorporated, and various routes of administration can be considered.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Chitosan; Drug delivery; Lipid membranes; Liposomes; Nanostructured lipid carriers; Solid lipid nanoparticles

Mesh:

Substances:

Year:  2017        PMID: 28414148     DOI: 10.1016/j.jconrel.2017.04.018

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  6 in total

Review 1.  Nanomedicines for Malaria Chemotherapy: Encapsulation vs. Polymer Therapeutics.

Authors:  Sindisiwe Mvango; William M R Matshe; Abideen O Balogun; Lynne A Pilcher; Mohammed O Balogun
Journal:  Pharm Res       Date:  2018-10-15       Impact factor: 4.200

2.  Metformin-loaded lecithin nanoparticles induce colorectal cancer cytotoxicity via epigenetic modulation of noncoding RNAs.

Authors:  Ahmed A Abd-Rabou; Ahmed M Abdelaziz; Olfat G Shaker; Ghada Ayeldeen
Journal:  Mol Biol Rep       Date:  2021-09-01       Impact factor: 2.316

3.  Self-Assembled Lecithin/Chitosan Nanoparticles Based on Phospholipid Complex: A Feasible Strategy to Improve Entrapment Efficiency and Transdermal Delivery of Poorly Lipophilic Drug.

Authors:  Wujun Dong; Jun Ye; Weijue Wang; Yanfang Yang; Hongliang Wang; Tong Sun; Lili Gao; Yuling Liu
Journal:  Int J Nanomedicine       Date:  2020-08-05

4.  Facile fabrication of a biocompatible composite gel with sustained release of aspirin for bone regeneration.

Authors:  Yunfan Zhang; Xueyu Dou; Lingyun Zhang; Hufei Wang; Ting Zhang; Rushui Bai; Qiannan Sun; Xing Wang; Tingting Yu; Decheng Wu; Bing Han; Xuliang Deng
Journal:  Bioact Mater       Date:  2021-10-05

5.  Designing siRNA/chitosan-methacrylate complex nanolipogel for prolonged gene silencing effects.

Authors:  Ye Cao; Yang Fei Tan; Yee Shan Wong; Muhammad Aminuddin; Bhuthalingam Ramya; Melvin Wen Jie Liew; Jiaxin Liu; Subbu S Venkatraman
Journal:  Sci Rep       Date:  2022-03-03       Impact factor: 4.379

6.  Biocompatible Fe-Based Micropore Metal-Organic Frameworks as Sustained-Release Anticancer Drug Carriers.

Authors:  Xin Leng; Xiaoxv Dong; Wenping Wang; Na Sai; Chunjing Yang; Longtai You; Hongliang Huang; Xingbin Yin; Jian Ni
Journal:  Molecules       Date:  2018-09-28       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.